Bomba de Insulina nos Planos de Saúde: Tema 1.316 do STJ e Cobertura Extrarrol
Anais do Encontro Nacional de Pós-graduação · 04.11.2026 · 10 (1)
DOI: 10.66221/n9kabp92 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anais do Encontro Nacional de Pós-graduação, online erschienen am 04.11.2026. Verfasst von Alessandra Silva und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives: to analyze how STJ Theme 1,316 applies the ADI 7,265 criteria for coverage outside the ANS list to continuous insulin infusion systems. Methods: qualitative, bibliographic and documentary legal research, with content analysis of legislation, ADI 7,265, Theme 1,316 and the motions for clarification decided in August 2026. Results: the STJ classified the system as a medical device, presumed general efficacy and ANS-assessment requirements satisfied, and kept individualized proof of clinical indication, lack of an adequate listed alternative, and regulatory registration. Limitation: documentary study of recent precedents. Conclusions: the ruling standardizes part of the evidentiary burden without removing case-specific technical review.
Zitieren
APA
Silva, A., Feitosa, J., & Khamis, R. (2026). Bomba de Insulina nos Planos de Saúde: Tema 1.316 do STJ e Cobertura Extrarrol. Anais do Encontro Nacional de Pós-graduação, 10(1). https://doi.org/10.66221/n9kabp92
Vancouver
Silva A, Feitosa J, Khamis R. Bomba de Insulina nos Planos de Saúde: Tema 1.316 do STJ e Cobertura Extrarrol. Anais do Encontro Nacional de Pós-graduação. 2026;10(1). doi:10.66221/n9kabp92
BibTeX
@article{Silva2026,
author = {Silva, Alessandra and Feitosa, Jessica and Khamis, Renato},
title = {Bomba de Insulina nos Planos de Saúde: Tema 1.316 do STJ e Cobertura Extrarrol},
journal = {Anais do Encontro Nacional de Pós-graduação},
year = {2026},
volume = {10},
number = {1},
doi = {10.66221/n9kabp92}
}
EUVIMED